Recombinant Human PRAME protein is a Human Full Length protein, in the 1 to 509 aa range, expressed in Wheat germ and suitable for SDS-PAGE, ELISA, WB.
M E R R R L R G S I Q S R Y I S M S V W T S P R R L V E L A G Q S L L K D E A L A I A A L E L L P R E L F P P L F M A A F D G R H S Q T L K A M V Q A W P F T C L P L G V L M K G Q H L H L E T F K A V L D G L D V L L A Q E V R P R R W K L Q V L D L R K N S H Q D F W T V W S G N R A S L Y S F P E P E A A Q P M T K K R K V D G L S T E A E Q P F I P V E V L V D L F L K E G A C D E L F S Y L I E K V K R K K N V L R L C C K K L K I F A M P M Q D I K M I L K M V Q L D S I E D L E V T C T W K L P T L A K F S P Y L G Q M I N L R R L L L S H I H A S S Y I S P E K E E Q Y I A Q F T S Q F L S L Q C L Q A L Y V D S L F F L R G R L D Q L L R H V M N P L E T L S I T N C R L S E G D V M H L S Q S P S V S Q L S V L S L S G V M L T D V S P E P L Q A L L E R A S A T L Q D L V F D E C G I T D D Q L L A L L P S L S H C S Q L T T L S F Y G N S I S I S A L Q S L L Q H L I G L S N L T H V L Y P V P L E S Y E D I H G T L H L E R L A Y L H A R L R E L L C E L G R P S M V W L S A N P C P H C G D R T F Y D P E P I L C P C F M P N
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application ELISA | Reactivity Reacts | Dilution info - | Notes - |
Application WB | Reactivity Reacts | Dilution info - | Notes - |
Select an associated product type
The protein expressed by gene PRAME functions as a transcriptional repressor, inhibiting retinoic acid signaling through retinoic acid receptors RARA, RARB, and RARG. It prevents retinoic acid-induced cell proliferation arrest, differentiation, and apoptosis. This supplementary information is collated from multiple sources and compiled automatically.
MAPE, OIP4, PRAME, Melanoma antigen preferentially expressed in tumors, Opa-interacting protein 4, Preferentially expressed antigen of melanoma, OIP-4
Recombinant Human PRAME protein is a Human Full Length protein, in the 1 to 509 aa range, expressed in Wheat germ and suitable for SDS-PAGE, ELISA, WB.
pH: 8
Constituents: 0.79% Tris HCl, 0.31% Glutathione
The protein expressed by gene PRAME functions as a transcriptional repressor, inhibiting retinoic acid signaling through retinoic acid receptors RARA, RARB, and RARG. It prevents retinoic acid-induced cell proliferation arrest, differentiation, and apoptosis.
This supplementary information is collated from multiple sources and compiled automatically.
Belongs to the PRAME family.
PRAME also known as Preferentially Expressed Antigen in Melanoma is a protein typically weighing around 50 kDa. It is found mostly in testis tissue but also appears in several types of tumors including melanoma and some leukemias. PRAME does not show significant expression in most normal tissues making it a potential target for cancer therapies. Immunohistochemistry (IHC) techniques such as PRAME IHC and PRAME staining often use monoclonal antibodies like mAb EPR20330 to detect PRAME protein presence in various samples.
PRAME acts as a repressor of retinoic acid signaling a process important for cell differentiation and growth. It does not directly form part of a complex but interacts with components involved in retinoic acid pathways. By binding to retinoic acid receptor complexes PRAME prevents activation of genes involved in cell cycle arrest and apoptosis contributing to unchecked cellular proliferation seen in certain cancers.
PRAME participates in the retinoic acid and various oncogenic signaling processes. It influences the retinoic acid pathway by interfering with the retinoic acid receptor (RAR) signaling. This interference with key proteins like RAR disrupts the normal regulatory processes that typically inhibit cancer progression. PRAME's modulation of these pathways highlights its role in promoting tumor growth and survival.
PRAME has significant relevance to cancer particularly melanoma. It is often used as a biomarker for melanoma identification due to its overexpression in such tumors. Additionally PRAME's connection to acute myeloid leukemia (AML) emerges from its ability to act similarly in diverse malignant cells. In these diseases the overexpression of PRAME interferes with normal differentiation processes and allows for sustained proliferation of malignant cells suggesting its potential role as a therapeutic target or diagnostic marker in oncology.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
12.5% SDS-PAGE analysis of ab132315 stained with Coomassie Blue.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com